• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富血供型肝内胆管细胞癌在 CT 动脉期有显著强化,提示手术预后较好。

Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.

机构信息

Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.

出版信息

J Surg Oncol. 2011 Aug 1;104(2):130-9. doi: 10.1002/jso.21917. Epub 2011 Mar 29.

DOI:10.1002/jso.21917
PMID:21448898
Abstract

BACKGROUND

Outcomes after hepatectomy in patients with mass-forming (MF) type intrahepatic cholangiocarcinoma (ICC) with marked enhancement within the tumor on arterial-phase computed tomography (CT) scans have not been clarified in detail.

METHODS

We retrospectively studied 140 patients with MF type ICC who underwent hepatectomy from 1989 through 2008. Surgical outcomes were compared between 25 patients with MF type ICC with marked enhancement within the tumor (hypervascular ICC) and 109 patients without enhancement within the tumor (hypovascular ICC) on arterial-phase CT scans.

RESULTS

Portal invasion and intrahepatic metastasis were significantly lower in patients with hypervascular ICC than in those with hypovascular ICC. The 5-year survival rate was significantly higher in patients with hypervascular ICC (86%) than in patients with hypovascular ICC (27%, P < 0.0001). Multivariate analysis showed hypervascular ICC on arterial-phase CT scans, normal level of cancer-associated carbohydrate antigen 19-9, absence of portal invasion, and absence of intrahepatic metastasis of ICC to be significant independent prognostic factors for overall survival in patients with MF type ICC.

CONCLUSIONS

MF type ICC with marked enhancement within the tumor on arterial CT scans showed a favorable surgical outcome due to its less invasive histopathologic characteristics in patients with MF type ICC.

摘要

背景

在动脉期 CT 扫描中肿瘤内明显增强的肿块型(MF)肝内胆管细胞癌(ICC)患者的肝切除术后结果尚未详细阐明。

方法

我们回顾性研究了 1989 年至 2008 年间接受肝切除术的 140 例 MF 型 ICC 患者。在动脉期 CT 扫描中,将 25 例肿瘤内明显增强(富血管 ICC)的 MF 型 ICC 患者与 109 例肿瘤内无增强(少血管 ICC)的患者进行比较,评估手术结果。

结果

与少血管 ICC 患者相比,富血管 ICC 患者的门静脉侵犯和肝内转移明显较低。富血管 ICC 患者的 5 年生存率明显高于少血管 ICC 患者(86% vs. 27%,P<0.0001)。多因素分析显示,动脉期 CT 扫描显示富血管 ICC、正常的癌相关碳水化合物抗原 19-9 水平、无门静脉侵犯和无 ICC 肝内转移是 MF 型 ICC 患者总生存的独立预后因素。

结论

动脉 CT 扫描中肿瘤内明显增强的 MF 型 ICC 具有较好的手术结果,这与其在 MF 型 ICC 患者中具有侵袭性较低的组织病理学特征有关。

相似文献

1
Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.富血供型肝内胆管细胞癌在 CT 动脉期有显著强化,提示手术预后较好。
J Surg Oncol. 2011 Aug 1;104(2):130-9. doi: 10.1002/jso.21917. Epub 2011 Mar 29.
2
Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma.延迟期动态CT增强作为肿块型肝内胆管癌的预后因素
Radiology. 2006 Jan;238(1):150-5. doi: 10.1148/radiol.2381041765. Epub 2005 Nov 22.
3
Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.对于无肝门侵犯的导管周围浸润型肝内胆管癌,手术治疗的效果优于无肝门侵犯的肿块型肝内胆管癌。
Hepatogastroenterology. 2010 Nov-Dec;57(104):1333-6.
4
The favorable prognosis after operative resection of hypervascular intrahepatic cholangiocarcinoma: A clinicopathologic and immunohistochemical study.肝内胆管癌手术切除后的良好预后:一项临床病理及免疫组化研究
Surgery. 2016 Sep;160(3):683-90. doi: 10.1016/j.surg.2016.03.020. Epub 2016 May 4.
5
Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.肝硬化患者肝内胆管细胞癌的血供比正常肝脏更为丰富。
Liver Int. 2012 Aug;32(7):1156-64. doi: 10.1111/j.1478-3231.2012.02783.x. Epub 2012 Mar 14.
6
A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.肝内肿块型胆管细胞癌的影像学分类提案:导管型和实质型——临床病理意义。
Eur Radiol. 2019 Jun;29(6):3111-3121. doi: 10.1007/s00330-018-5898-9. Epub 2018 Dec 17.
7
Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.基于多变量分析的增强 CT 表现对肿块型肝内胆管细胞癌与低分化肝细胞癌的鉴别诊断
Abdom Radiol (NY). 2016 May;41(5):978-89. doi: 10.1007/s00261-015-0629-z.
8
Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.大细胞型肝内胆管细胞癌患者肝切除术后的临床病理预后因素:淋巴血管侵犯指数的相关性。
Ann Surg Oncol. 2010 Jul;17(7):1816-22. doi: 10.1245/s10434-010-0929-z. Epub 2010 Feb 5.
9
Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.对比增强计算机断层扫描成像上的瘤内动脉:鉴别肝内胆管癌与低分化肝细胞癌。
Abdom Imaging. 2015 Aug;40(6):1492-9. doi: 10.1007/s00261-015-0352-9.
10
Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics.肝内胆管癌:通过测量衰减评估肿瘤影像增强与临床病理特征之间的关系
Abdom Imaging. 2013 Aug;38(4):785-92. doi: 10.1007/s00261-012-9974-3.

引用本文的文献

1
Imaging findings of intrahepatic cholangiocarcinoma for prognosis prediction and treatment decision-making: a narrative review.用于预后预测和治疗决策的肝内胆管癌影像学表现:一项叙述性综述
Ewha Med J. 2024 Oct;47(4):e66. doi: 10.12771/emj.2024.e66. Epub 2024 Oct 31.
2
Outcomes of liver resection in hepatitis C virus-related intrahepatic cholangiocarcinoma: A systematic review and meta-analysis.丙型肝炎病毒相关肝内胆管癌肝切除的结果:一项系统评价和荟萃分析。
World J Virol. 2024 Mar 25;13(1):88946. doi: 10.5501/wjv.v13.i1.88946.
3
Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review.
世界卫生组织肝内胆管癌亚型分类的外科解读:一篇综述
Surg Today. 2025 Jan;55(1):1-9. doi: 10.1007/s00595-024-02825-x. Epub 2024 Apr 2.
4
Imaging features based on CT and MRI for predicting prognosis of patients with intrahepatic cholangiocarcinoma: a single-center study and meta-analysis.基于 CT 和 MRI 的影像学特征预测肝内胆管细胞癌患者预后的单中心研究和荟萃分析。
Cancer Imaging. 2023 Jun 7;23(1):56. doi: 10.1186/s40644-023-00576-5.
5
Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.日本肝癌研究组肝内胆管癌临床实践指南
Liver Cancer. 2022 Feb 23;11(4):290-314. doi: 10.1159/000522403. eCollection 2022 Jul.
6
Subtype Classification of Intrahepatic Cholangiocarcinoma Using Liver MR Imaging Features and Its Prognostic Value.利用肝脏磁共振成像特征对肝内胆管癌进行亚型分类及其预后价值
Liver Cancer. 2022 Mar 30;11(3):233-246. doi: 10.1159/000521747. eCollection 2022 Jun.
7
Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations.肝内胆管癌亚型的综合分析以改善患者分层:临床、病理和影像学考量
Cancers (Basel). 2022 Jun 28;14(13):3156. doi: 10.3390/cancers14133156.
8
Intrahepatic Cholangiocarcinoma With Neither Intrahepatic Metastasis Nor Lymph Node Metastasis Is the Optimal Indication for Hepatectomy With Adjuvant Therapy.既无肝内转移也无淋巴结转移的肝内胆管癌是肝切除联合辅助治疗的最佳适应证。
Cancer Diagn Progn. 2022 Mar 3;2(2):160-166. doi: 10.21873/cdp.10090. eCollection 2022 Mar-Apr.
9
Signal enhancement ratio of CE-MRI: a potential biomarker of survival after hepatic arterial infusion chemotherapy in biliary tract cancers.对比增强磁共振成像的信号增强率:胆管癌肝动脉灌注化疗后生存的潜在生物标志物。
Insights Imaging. 2022 Mar 14;13(1):46. doi: 10.1186/s13244-022-01188-6.
10
Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.肝内肿块型胆管细胞癌及其模拟病变的影像学表现:MRI 如何对其进行鉴别。
Curr Oncol. 2022 Jan 30;29(2):698-723. doi: 10.3390/curroncol29020061.